FI903929A0 - Proteiner som induserar immunologisk effektorcellaktivation och kemattraktion. - Google Patents

Proteiner som induserar immunologisk effektorcellaktivation och kemattraktion.

Info

Publication number
FI903929A0
FI903929A0 FI903929A FI903929A FI903929A0 FI 903929 A0 FI903929 A0 FI 903929A0 FI 903929 A FI903929 A FI 903929A FI 903929 A FI903929 A FI 903929A FI 903929 A0 FI903929 A0 FI 903929A0
Authority
FI
Finland
Prior art keywords
kemattraktion
induserar
immunologisk
effektorcellaktivation
proteiner
Prior art date
Application number
FI903929A
Other languages
English (en)
Inventor
Harvey I Cantor
Roberto Patarca
Joel L Schwartz
Gordon J Freeman
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Publication of FI903929A0 publication Critical patent/FI903929A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pain & Pain Management (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI903929A 1988-02-09 1990-08-08 Proteiner som induserar immunologisk effektorcellaktivation och kemattraktion. FI903929A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/153,887 US5049659A (en) 1988-02-09 1988-02-09 Proteins which induce immunological effector cell activation and chemattraction
PCT/US1989/000496 WO1989007613A1 (en) 1988-02-09 1989-02-08 Proteins which induce immunological effector cell activation and chemattraction

Publications (1)

Publication Number Publication Date
FI903929A0 true FI903929A0 (fi) 1990-08-08

Family

ID=22549146

Family Applications (1)

Application Number Title Priority Date Filing Date
FI903929A FI903929A0 (fi) 1988-02-09 1990-08-08 Proteiner som induserar immunologisk effektorcellaktivation och kemattraktion.

Country Status (8)

Country Link
US (1) US5049659A (fi)
EP (1) EP0406257A4 (fi)
JP (1) JPH03502453A (fi)
KR (1) KR900700607A (fi)
AU (1) AU628806B2 (fi)
DK (1) DK189090A (fi)
FI (1) FI903929A0 (fi)
WO (1) WO1989007613A1 (fi)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03500244A (ja) * 1987-09-28 1991-01-24 ラ　ジョラ　キャンサー　リサーチ　ファウンデーション 細胞接着性が増大した細胞の選別
IL88831A0 (en) * 1988-12-29 1989-07-31 Yeda Res & Dev Blood assay
US5206023A (en) * 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
US5304496A (en) * 1991-06-10 1994-04-19 Children's Hospital Of Philadelphia Biological regulation of mineralization
US5270300A (en) * 1991-09-06 1993-12-14 Robert Francis Shaw Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone
US5268364A (en) * 1991-12-12 1993-12-07 The Biomembrane Institute Method for inhibiting selectin-dependent adhesion of leukocytes and platelets by O-glycosylation modification
ES2185630T3 (es) * 1992-04-30 2003-05-01 Innogenetics Nv Nuevos polipeptidos y peptidos, acidos nucleicos que los codifican, y su utilizacion en el campo de la terapia de tumores, inflamacion o inmunologia.
DE4310632A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Lineare Adhäsionsinhibitoren
US5695761A (en) * 1993-12-23 1997-12-09 Rutgers University Suppression of nitric oxide production by osteopontin
US6159748A (en) * 1995-03-13 2000-12-12 Affinitech, Ltd Evaluation of autoimmune diseases using a multiple parameter latex bead suspension and flow cytometry
IL114140A (en) * 1995-06-14 2000-06-01 Hadasit Med Res Service Anti-metastatic and anti-angiogenetic pharmaceutical compositions
US5837247A (en) * 1995-06-16 1998-11-17 United States Of America As Represented By The Public Health Service National Institutes Of Health Chemotactic agents for t-cells
US6995018B1 (en) * 1999-04-09 2006-02-07 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Complex formed by N-linked glycoproteins (SIBLINGS)and Factor H
WO2000063247A2 (en) * 1999-04-15 2000-10-26 Children's Medical Center Corporation Osteopontin-derived chemotactic and inhibitory agents and uses therefor
IL145850A0 (en) * 1999-04-16 2002-07-25 Childrens Medical Center Adhesion modulatory peptides and methods for use
US8914114B2 (en) 2000-05-23 2014-12-16 The Feinstein Institute For Medical Research Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
US20050048614A1 (en) * 2000-06-13 2005-03-03 Children's Medical Center Corporation Biosynthetic oncolytic molecules and uses therefor
AU2002213346B2 (en) * 2000-10-18 2006-05-11 Children's Medical Center Corporation Osteopontin-coated surfaces and methods of use
WO2004013311A2 (en) 2002-08-06 2004-02-12 Diadexus, Inc. Compositions and methods relating to ovarian specific genes and proteins
US10912712B2 (en) 2004-03-25 2021-02-09 The Feinstein Institutes For Medical Research Treatment of bleeding by non-invasive stimulation
WO2005092308A2 (en) 2004-03-25 2005-10-06 The Feinstein Institute For Medical Research Neural tourniquet
CA2571710A1 (en) 2004-06-24 2006-11-02 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
US11207518B2 (en) 2004-12-27 2021-12-28 The Feinstein Institutes For Medical Research Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway
CA2593079C (en) 2004-12-27 2014-08-19 North Shore-Long Island Jewish Research Institute Treating inflammatory disorders by electrical vagus nerve stimulation
WO2009029614A1 (en) * 2007-08-27 2009-03-05 The Feinstein Institute For Medical Research Devices and methods for inhibiting granulocyte activation by neural stimulation
US9662490B2 (en) 2008-03-31 2017-05-30 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
WO2009146030A1 (en) 2008-03-31 2009-12-03 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation of t-cell activity
CN102215909B (zh) 2008-11-18 2014-09-10 赛博恩特医疗器械公司 优化用于消炎刺激的电极放置的装置和方法
US8996116B2 (en) 2009-10-30 2015-03-31 Setpoint Medical Corporation Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
US9211410B2 (en) 2009-05-01 2015-12-15 Setpoint Medical Corporation Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US20110054569A1 (en) * 2009-09-01 2011-03-03 Zitnik Ralph J Prescription pad for treatment of inflammatory disorders
AU2010258792B2 (en) 2009-06-09 2015-07-02 Setpoint Medical Corporation Nerve cuff with pocket for leadless stimulator
US11051744B2 (en) 2009-11-17 2021-07-06 Setpoint Medical Corporation Closed-loop vagus nerve stimulation
US9833621B2 (en) 2011-09-23 2017-12-05 Setpoint Medical Corporation Modulation of sirtuins by vagus nerve stimulation
CN102821814B (zh) 2009-12-23 2015-07-15 赛博恩特医疗器械公司 用于治疗慢性炎症的神经刺激设备和系统
WO2012154865A2 (en) 2011-05-09 2012-11-15 Setpoint Medical Corporation Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US9572983B2 (en) 2012-03-26 2017-02-21 Setpoint Medical Corporation Devices and methods for modulation of bone erosion
US11311725B2 (en) 2014-10-24 2022-04-26 Setpoint Medical Corporation Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
WO2016126807A1 (en) 2015-02-03 2016-08-11 Setpoint Medical Corporation Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
US10596367B2 (en) 2016-01-13 2020-03-24 Setpoint Medical Corporation Systems and methods for establishing a nerve block
CN114904142A (zh) 2016-01-20 2022-08-16 赛博恩特医疗器械公司 迷走神经刺激的控制
US11471681B2 (en) 2016-01-20 2022-10-18 Setpoint Medical Corporation Batteryless implantable microstimulators
WO2017127758A1 (en) 2016-01-20 2017-07-27 Setpoint Medical Corporation Implantable microstimulators and inductive charging systems
US10583304B2 (en) 2016-01-25 2020-03-10 Setpoint Medical Corporation Implantable neurostimulator having power control and thermal regulation and methods of use
US11173307B2 (en) 2017-08-14 2021-11-16 Setpoint Medical Corporation Vagus nerve stimulation pre-screening test
US11260229B2 (en) 2018-09-25 2022-03-01 The Feinstein Institutes For Medical Research Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
WO2021236977A1 (en) 2020-05-21 2021-11-25 The Feinstein Institutes For Medical Research Systems and methods for vagus nerve stimulation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4792525A (en) * 1982-08-04 1988-12-20 La Jolla Cancer Research Foundation Tetrapeptide

Also Published As

Publication number Publication date
EP0406257A1 (en) 1991-01-09
JPH03502453A (ja) 1991-06-06
DK189090A (da) 1990-10-08
DK189090D0 (da) 1990-08-08
AU628806B2 (en) 1992-09-24
KR900700607A (ko) 1990-08-16
AU3192989A (en) 1989-09-06
US5049659A (en) 1991-09-17
WO1989007613A1 (en) 1989-08-24
EP0406257A4 (en) 1993-03-31

Similar Documents

Publication Publication Date Title
FI893105A0 (fi) Tryckkapsel foer spraybehaollare och spraybehaollare som utnyttjar en saodan kapsel.
FI903929A0 (fi) Proteiner som induserar immunologisk effektorcellaktivation och kemattraktion.
FI890117A0 (fi) Databehandlingssystem och i detta anvaendbar bildprocessor.
FI893334A (fi) Trycksensitiva bindemedel som innehaoller en alkoxifunktionell kiselfoerening.
FI896138A0 (fi) Polyolpolyestrar som fuktighetsbarriaer foer livsmedel.
FI922454A0 (fi) Peptider och antikroppar som inhiberar integrinligandbindning.
FI881070A0 (fi) Foerfarande i integrerad ir-tork/ yankeekaopa och ir-tork/yankeekaopa.
FI894176A0 (fi) Foerfarande och anordning foer etikettering.
FI900045A0 (fi) Proteasfattiga gram-positiva bakterier och anvaendning daerav som vaerdorganism foer framstaellning av rekombinationsprodukter.
FI891411A (fi) Neopentylesterderivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI890098A (fi) Pyrazol- och indazolpyridinaminer, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI875707A0 (fi) Mycket fyllaemne innehaollande fenolhartsskumplaster och deras anvaendning som isolerformkroppar.
FI890033A (fi) Bildskaermanordning som innehaoller en vaogformsgenerator.
FI890147A (fi) Aemnen som motverkar rytmstoerningar.
FI884001A0 (fi) Siltrumma och foerfarande foer framstaellning daerav.
FI891409A0 (fi) Dietylenglykolmonoestrar, foerfaranden foer deras framstaellning och deras framstaellning och deras anvaendning som laekemedel.
FI894280A (fi) Foerbaettringar i blandningsapparater foer vaetskor och gaser.
FI895683A0 (fi) Foerfarande och anordning foer provtagning.
FI895603A0 (fi) Penemderivat och foerfarande foer deras framstaellning.
FI902177A0 (fi) Kompositioner som innehaoller elastomerer och icke-karboniserade, metaller innehaollande komplex.
FI910235A0 (fi) Ytbelaeggningskompositioner och i dessa anvaendbara polyanhydrider.
FI912063A0 (fi) 2-aminokarboxylsyraderivat, deras framstaellning och anvaendning som laekemedel.
FI894664A (fi) Inpassningskil foer vaeggelement som skall sammanfogas.
FI880902A0 (fi) Landsvaegskonstruktion som minskar spaorbildning.
FI881591A0 (fi) Vaermeradiator som lagrar vaermeenergi.

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: DANA FARBER CANCER INSTITUTE